AIMS Faridabad gives Disfigured Swedish Woman a Winsome Face

Faridabad: It was a complete transformation- a disfigured face of a man turning into winsome one, thanks to flawless surgery done in Asian Institute of Medical Sciences (AIMS). The Swedish woman under knife suffered from Neurofibromatosis, a group of rare genetic disorders that cause tumours to form on nerve tissue.

Anna, a 27 yrs female from Sweden visited Dr Manish Nanda at Asian Institute of Medical Sciences for the treatment of her severely disfigured face following a genetically inherited disorder called Neurofibromatosis. The rare genetic disorder results in formation of tumors anywhere in the nervous system, including the brain, spinal cord and nerves. There is no cure for the disease, generally, the sooner someone is under the care of a doctor trained in treating neurofibromatosis, the better the outcome.

The young Swedish national consulted several renowned doctors worldwide, but all her efforts were futile leaving her with no hope to get proper treatment for her condition. The disease not only affected her physically but shook her confidence as well. A highly social person, she now shied away from meeting people. Finally, she landed in India and found the much-needed confidence in Dr. Manish Nanda, Cosmetic Surgeon at Asian Institute of Medical Sciences, Faridabad. From there on, things moved on smoothly for the Swedish woman.

After reviewing the patient’s condition, Dr. Nanda said, “Anna’s case was full of challenges – with hundreds of tumors of all different sizes covering her entire face. The sheer number of facial tumors made their surgical removal a huge challenge in itself. Moreover, there were other considerations involved in her treatment that further made the work even more daunting. Being an international patient, we were presented with the huge task of delivering maximum results in a limited time frame and at a promised cost. Calculated strategic moves had to be developed preoperatively for safe removal and for optimal results.”

Sharing details of the surgery, Dr. Manish added, “her treatment necessitated the use of highly advanced and specialised surgical equipment, state-of-the-art aesthetic lasers, botox injections, fillers and skin brightening procedures. Moving ahead with a tactical strategy, we were able to offer her a cheerful and a more confident face for the rest of her life.”

According to the team at Asian, Anna will be able to lead a normal life without any further complications. Anna expressed a deep sense of gratitude to Dr. Nanda and his team at Asian Hospital.

  • Related Posts

    • Health
    • January 10, 2025
    • 894 views
    Indian Surgical Robot Mantra pulled off World first Cardiac Telesurgeries

    New Delhi: India scripted World History when world’s first robotic cardiac telesurgeries were meticulously performed over a distance of 286 Km using best of class Made in India surgical robot…

    • Health
    • February 10, 2024
    • 374 views
    Appointment of CEO packs a Punch in NeuroEqulibrium’s Global Goal

    New Delhi: The ambition of NeuroEquilibrium gets a shot in the arm with the appointment of industry vetran Samit Verma as its CEO (Chief Executive Officer). Its global aspiration will…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    SHRC orders criminal proceedings against fake doctor

    SHRC orders criminal proceedings against fake doctor

    Karnataka home to hundreds of startups in med, pharma sectors: Minister MB Patil

    Karnataka home to hundreds of startups in med, pharma sectors: Minister MB Patil

    Piramal Pharma arm, BrePco Biopharma get UKMHRA approval for Neoatricon in UK

    Piramal Pharma arm, BrePco Biopharma get UKMHRA approval for Neoatricon in UK

    Medical shop sealed for illegal sale of psychotropic drugs

    Medical shop sealed for illegal sale of psychotropic drugs

    Popular diabetes drug, Mounjaro, launched in India

    Popular diabetes drug, Mounjaro, launched in India

    Pharma industry says UK pricing revenue unsustainable, blocking investments

    Pharma industry says UK pricing revenue unsustainable, blocking investments